Initial experience with the novel p64MW HPC flow diverter from a cohort study in unruptured anterior circulation aneurysms under dual antiplatelet medication.
CONCLUSION: p64MW HPC implantation in patients under dual antiplatelet therapy with or without dual platelet function inhibition has a low procedural complication rate. The early aneurysm occlusion rate is high.
PMID: 32640858 [PubMed - as supplied by publisher]
Source: Interventional Neuroradiology - Category: Radiology Tags: Interv Neuroradiol Source Type: research
More News: Angiography | Angioplasty | Aspirin | Baloon Angioplasty | Brain | Clopidogrel | Mongolia Health | Neurology | Plavix | Radiology | Study | Thrombosis